Practice 9 structured short- and long-answer medical questions on Gastropathology Pathology. Review model answers for exam revision.
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: Model answer pending
Answer: This comprehensive study guide details the pathology of various tumours affecting the gastrointestinal tract, covering the oesophagus, stomach, colon, and appendix. It provides an overview of oesophageal adenocarcinoma and squamous cell carcinoma, highlighting their distinct risk factors, locations, and demographics. Gastric tumours discussed include different types of polyps, adenocarcinoma (intestinal vs. diffuse), MALT lymphoma, carcinoid tumours, and GIST, with emphasis on their aetiology, morphology, and unique clinical features like linitis plastica and carcinoid syndrome. The colorectal section elaborates on non-neoplastic and neoplastic polyps, detailing two major genetic syndromes, Familial Adenomatous Polyposis (FAP) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC), contrasting their genetic basis and clinical presentation. Colorectal adenocarcinoma and its prognostic factors are also addressed. Finally, appendix tumours, specifically carcinoid and adenocarcinoma, are described, along with the severe complication of Pseudomyxoma Peritonei. The document concludes with quick-reference tables and high-yield facts to aid in understanding and recall of crucial information. ## Key Points - **Oesophageal Adenocarcinoma**: Arises in the distal 1/3, primarily in white males with Barrett oesophagus as a precursor. Associated with TP53 mutations. - **Oesophageal Squamous Cell Carcinoma (SCC)**: Found in the middle 1/3, strongly linked to alcohol and tobacco synergy, and HPV in high-risk regions. - **Gastric Adenocarcinoma (Intestinal Type)**: Typically bulky, discrete, gland-forming tumours. - **Gastric Adenocarcinoma (Diffuse Type)**: Characterized by signet ring cells, diffuse infiltration, and can lead to "Linitis Plastica" (leather bottle stomach). - **Gastric MALT Lymphoma**: Develops secondary to chronic *H. pylori* gastritis; early-stage disease may regress with *H. pylori* eradication. - **Carcinoid Tumours**: Neuroendocrine tumours, most common in GIT. Carcinoid syndrome occurs when liver metastases are present, allowing vasoactive substances to bypass hepatic metabolism. - **Gastrointestinal Stromal Tumour (GIST)**: Most common mesenchymal tumour of the abdomen, arising from Interstitial Cells of Cajal, driven by activating mutations in c-KIT or PDGFRA tyrosine kinases, treatable with Imatinib. - **Neoplastic Colorectal Polyps (Adenomas)**: Characterized by cytologic dysplasia, these are precursors to colonic adenocarcinoma. - **Familial Adenomatous Polyposis (FAP)**: Caused by APC gene mutation, leading to >100 adenomatous polyps and near-certain colorectal cancer by age 30 if untreated. - **Hereditary Non-Polyposis Colorectal Cancer (HNPCC)/Lynch Syndrome**: Due to DNA mismatch repair gene defects, resulting in microsatellite instability and colorectal cancer at an earlier age than sporadic cases, but with fewer polyps than FAP. - **Colorectal Adenocarcinoma Prognosis**: Determined by depth of invasion (T stage) and presence/absence of lymph node metastases (N stage). - **Appendix Carcinoid**: Most common appendix tumour, usually benign, often an incidental finding at the distal tip. - **Pseudomyxoma Peritonei**: A severe complication of mucin-producing appendiceal tumours, where the abdomen fills with tenacious mucin, often ultimately fatal. ## Detailed Notes ### Oesophagus ### Oesophageal Adenocarcinoma **Who**: White males; 7× more common in men; highest in developed Western countries; one of the fastest-rising cancers in incidence **Risk Factors**: Barrett oesophagus, chronic GERD, documented dysplasia, tobacco, obesity, radiation | Protective: fruits & vegetables **Pathogenesis** Each step = accumulation of genetic + epigenetic changes. Epithelial clones from non-dysplastic Barrett persist and accumulate mutations over time. **Morphology** * **Location**: Distal 1/3 of oesophagus; may invade gastric cardia * **Gross**: Early = flat/raised patches → Late = exophytic mass OR ulcerated OR diffusely infiltrating * **Microscopy**: Mucin-producing, gland-forming tumour; Barrett oesophagus present adjacent to tumour ### Oesophageal Squamous Cell Carcinoma (SCC) **Who**: Adults >45 yrs; males 4× more; 6× more in African Americans than whites (NOT fully explained by alcohol/tobacco); incidence varies >100-fold between countries **High-incidence countries**: Iran, central China, Hong Kong, Argentina, Brazil, South Africa **Risk Factors**: Alcohol + tobacco (synergistic), poverty, nutritional deficiencies, caustic oesophageal injury, achalasia, Plummer-Vinson syndrome, very hot beverages, mediastinal radiation, polycyclic hydrocarbons, nitrosamines, fungus-contaminated foods, HPV (high-risk regions only) **Pathogenesis** **Morphology** * **Location**: Middle 1/3 of oesophagus (contrast: adenocarcinoma = distal 1/3) * **Gross**: Early = small grey-white plaque-like thickenings → Later = polypoid/obstructing OR ulcerated OR diffusely infiltrative (wall thickening + luminal narrowing) * **Microscopy**: Moderately to well differentiated; variants = verrucous, spindle cell, basaloid SCC * **Invasion of surrounding structures**: * Respiratory tree → pneumonia * Aorta → catastrophic haemorrhage * Mediastinum + pericardium * **Spread**: Rich submucosal lymphatics → circumferential + longitudinal spread; skip lesions (intramural nodules several cm from main mass) **Lymph Node Metastases by Location** | Location | LN Spread | | :---------- | :----------------------------- | | Upper 1/3 | Cervical nodes | | Middle 1/3 | Mediastinal, paratracheal, tracheobronchial | | Lower 1/3 | Gastric + coeliac nodes | ### Clinical Features — Both Oesophageal Tumours Dysphagia → Odynophagia → Obstruction → Weight loss → Haemorrhage → Sepsis First symptom may be aspiration of food via tracheoesophageal fistula Symptomatic tumours are generally very large at diagnosis ### Adenocarcinoma vs SCC | Feature | Adenocarcinoma | SCC | | :------------ | :-------------------------- | :--------------------------- | | Location | Distal 1/3 | Middle 1/3 | | Precursor | Barrett oesophagus | Squamous dysplasia | | Key mutation | TP53, chromosomal | Alcohol + tobacco | | Demographics | White males, Western | African Americans, rural/developing | | HPV | No | Yes (high-risk regions) | | Microscopy | Glands + mucin | Squamous differentiation | ### Stomach ### Gastric Polyps **Inflammatory & Hyperplastic Polyps** * Reactive lesions associated with chronic gastritis * Risk of dysplasia increases with polyp size * No significant malignant potential on their own **Gastric Adenomas** * Arise in background of chronic gastritis + intestinal metaplasia + glandular (mucosal) atrophy * Premalignant — adenocarcinoma frequently arises within them * Require complete excision + surveillance for recurrence ### Gastric Adenocarcinoma **Who**: More common in lower socioeconomic groups; marked geographic variation **Aetiology**: *H. pylori* (most common), chronic atrophic gastritis, EBV infection → multiple pathways of neoplastic transformation **Two Major Histologic Types** | Feature | Intestinal Type | Diffuse Type | | :------ | :-------------------------- | :------------------------------ | | Growth | Bulky, discrete, may be ulcerated | Diffuse infiltration | | Cells | Gland-forming | Signet ring cells | | Wall | Discrete mass | Thickened → Linitis Plastica | **Linitis Plastica**: "leather bottle stomach" — diffuse signet ring cell infiltration thickens entire gastric wall without forming a discrete mass **Classification**: Based on location + gross + histologic morphology ### Gastric MALT Lymphoma * Derived from mucosa-associated lymphoid tissue (MALT) * MALT is not normally present in the stomach — develops in response to chronic *H. pylori* gastritis * *H. pylori* eradication → tumour regression in early-stage disease * Most common primary gastric lymphoma ### Carcinoid Tumours * Arise from diffuse neuroendocrine system (enterochromaffin/APUD cells) - Most common in the GIT, particularly the small intestine **Prognosis by location** | Location | Behaviour | | :------------ | :------------------ | | Small intestine | Most aggressive | | Appendix | Almost always benign | **Carcinoid Syndrome** (occurs when liver mets are present — vasoactive substances bypass liver) * Cutaneous flushing * Sweating * Bronchospasm * Colicky abdominal pain * Diarrhoea * Right-sided cardiac valvular fibrosis ### Gastrointestinal Stromal Tumour (GIST) * Most common mesenchymal tumour of the abdomen * Most often located in the stomach * Arises from Interstitial Cells of Cajal (pacemaker cells of the GIT) * **Mutations**: Activating mutations in c-KIT or PDGFRA tyrosine kinases * **Treatment**: Responds to tyrosine kinase inhibitors (e.g. Imatinib/Gleevec) ### Clinical Features (Stomach tumours generally) * Abdominal swelling + pain * Vomiting * Gastric outlet obstruction ### Colon ### Colorectal Polyps **Non-Neoplastic Polyps** | Type | Origin | Malignant Potential | | :------------ | :------------------------------- | :----------------------------------------------- | | Inflammatory | Chronic cycles of injury + healing | None | | Hamartomatous | Sporadic or genetic (e.g. Peutz-Jeghers) | Some (when part of genetic syndrome) | | Hyperplastic | Benign epithelial proliferation; left colon + rectum | None — must be distinguished from sessile serrated adenomas | **Neoplastic Polyps (Adenomas)** * Hallmark = cytologic dysplasia * Precursors of colonic adenocarcinoma * Sessile serrated adenomas = lack cytologic dysplasia but share morphology with hyperplastic polyps; still carry malignant potential ### Familial Adenomatous Polyposis (FAP) * **Gene**: APC mutation (tumour suppressor gene, chromosome 5) * **Features**: >100 adenomatous polyps; colorectal cancer almost certain by age 30 if untreated * **Pathway**: APC loss → uncontrolled cell proliferation → massive polyposis → carcinoma * Represents the chromosomal instability (CIN) pathway ### HNPCC — Lynch Syndrome * **Gene**: DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2) * **Features**: Fewer polyps than FAP; cancer develops earlier than sporadic CRC but later than FAP * **Pathway**: Defective mismatch repair → microsatellite instability (MSI) → carcinoma * Represents the microsatellite instability pathway ### FAP vs HNPCC | Feature | FAP | HNPCC | | :-------------- | :-------------------- | :-------------------------- | | Gene | APC | Mismatch repair genes | | Polyp number | >100 | Few | | Cancer age | <30 yrs | Older than FAP, younger than sporadic | | Pathway | Chromosomal instability | Microsatellite instability | ### Colorectal Adenocarcinoma * Vast majority of colonic cancers are adenocarcinomas - Both FAP and HNPCC pathways also contribute to sporadic colon cancer * **Two Most Important Prognostic Factors**: 1. Depth of invasion (T stage) 2. Presence or absence of lymph node metastases (N stage) ### Appendix ### Appendix Tumours **Carcinoid (Most Common Appendix Tumour)** * Usually an incidental finding at surgery or on resected appendix * Located at distal tip of appendix * Forms solid bulbous swelling up to 2–3 cm * Intramural + transmural extension may occur but nodal mets very rare; distant spread exceptional * Almost always benign **Adenocarcinoma of the Appendix** * Invasion through appendiceal wall → intraperitoneal seeding * In women, peritoneal implants may mimic mucinous ovarian tumours **Pseudomyxoma Peritonei** * Most advanced complication of mucin-producing appendiceal tumours * Abdomen fills with tenacious, semisolid mucin * Managed by repeated debulking * Disease may be held in check for years but is ultimately fatal in most cases ### Master Quick-Reference Table | Tumour | Location | Key Feature | | :------------------------- | :---------------- | :---------------------------------------------- | | Oesophageal Adenocarcinoma | Distal 1/3 | Barrett oesophagus precursor; TP53 mutation | | Oesophageal SCC | Middle 1/3 | Alcohol + tobacco synergy; HPV in high-risk areas | | Gastric Adenocarcinoma | Stomach | *H. pylori*; signet ring cells; linitis plastica | | Gastric MALT Lymphoma | Stomach | *H. pylori* induced; regresses with eradication | | GIST | Stomach | c-KIT mutation; Cajal cells; Imatinib | | Carcinoid | Small intestine/Appendix | Carcinoid syndrome; appendix = benign | | FAP | Colon | APC mutation; >100 polyps; cancer <30 yrs | | HNPCC | Colon | Mismatch repair defect; microsatellite instability | | Colorectal Adenocarcinoma | Colon | Depth + LN mets = prognosis | | Appendix Carcinoid | Distal tip appendix | Incidental; almost always benign | | Pseudomyxoma Peritonei | Peritoneum | Mucin-filled abdomen; ultimately fatal | ### High-Yield Exam Facts * Barrett oesophagus = columnar metaplasia replacing squamous epithelium due to chronic GERD * Adenocarcinoma progression = GERD → Barrett → Low-grade dysplasia → High-grade dysplasia → Carcinoma * TP53 + chromosomal abnormalities = early in oesophageal adenocarcinoma * Oesophageal SCC = middle 1/3; Adenocarcinoma = distal 1/3 * Alcohol + tobacco = synergistic in SCC * HPV in SCC = high-risk geographic regions only * Linitis plastica = signet ring cell diffuse infiltration of gastric wall * MALT lymphoma = *H. pylori* induced; eradication can cause regression * GIST = Interstitial cells of Cajal + c-KIT/PDGFRA mutations + Imatinib treatment * Carcinoid syndrome = liver metastases required (vasoactive substances bypass liver) * Carcinoid: small intestine = aggressive; appendix = benign * Hyperplastic polyps = NO malignant potential + found in left colon/rectum * Sessile serrated adenomas = no dysplasia but still premalignant * FAP = APC mutation + >100 polyps + cancer <30 yrs * HNPCC = mismatch repair + microsatellite instability + fewer polyps * Colorectal Ca prognosis = depth of invasion + LN status * Appendix carcinoid = most common appendix tumour; almost always benign * Pseudomyxoma peritonei = mucin-filled abdomen; ultimately fatal * Peritoneal implants from appendix adenocarcinoma in women = mimic mucinous ovarian tumours ## Practice Questions